510(k) K200788
K200788 is an FDA 510(k) premarket notification submitted by Arkray, Inc. for the device "Assure Titanium Blood Glucose Monitoring System". The FDA issued a decision of Substantially Equivalent on May 23, 2022. The device falls under product code PZI (Prescription Use Blood Glucose Meter For Near-Patient Testing), a Class II device regulated under 21 CFR 862.1345. Arkray, Inc. has 17 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 23, 2022
- Date Received
- Mar 26, 2020
- Clearance Type
- Dual Track
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Prescription Use Blood Glucose Meter For Near-Patient Testing
- Device Class
- Class II
- Regulation Number
- 862.1345
- Review Panel
- CH
- Submission Type
- 510(k)
Intended for use in near-patient testing settings for in vitro diagnostic, multiple-patient use for the quantitative determination of glucose throughout all hospital and all professional healthcare settings for use in determining dysglycemia.
Need the full FDA record for Arkray, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.